Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Interest Expense : ¥-76 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing King-Friend Biochemical Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nanjing King-Friend Biochemical Pharmaceutical Co's interest expense for the three months ended in Sep. 2024 was ¥ -17 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-76 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nanjing King-Friend Biochemical Pharmaceutical Co's Operating Income for the three months ended in Sep. 2024 was ¥ 292 Mil. Nanjing King-Friend Biochemical Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2024 was ¥ -17 Mil. Nanjing King-Friend Biochemical Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 was 16.97. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nanjing King-Friend Biochemical Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Nanjing King-Friend Biochemical Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing King-Friend Biochemical Pharmaceutical Co Interest Expense Chart

Nanjing King-Friend Biochemical Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-22.10

-57.57

-92.22

-57.85

-81.05

Nanjing King-Friend Biochemical Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Expense	Get a 7-Day Free Trial															-24.30	-16.62	-20.16	-22.49	-17.18

Nanjing King-Friend Biochemical Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-76 Mil.

Nanjing King-Friend Biochemical Pharmaceutical Co (SHSE:603707) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nanjing King-Friend Biochemical Pharmaceutical Co's Interest Expense for the three months ended in Sep. 2024 was ¥-17 Mil. Its Operating Income for the three months ended in Sep. 2024 was ¥292 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ¥827 Mil.

Nanjing King-Friend Biochemical Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2024 )	/	Interest Expense (Q: Sep. 2024 )
	=	-1	*	291.534	/	-17.184
	=	16.97

The higher the ratio, the stronger the company's financial strength is.

Nanjing King-Friend Biochemical Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

1/16 Xuefu Road, Nanjing High-Tech Zone, Nanjing, CHN, 210061

Website

http://www.nkf-pharma.com

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is a China-based company engaged in the research and development, import and export of medicines and health products. The main products of the company are Heparin sodium and low molecular weight heparin. Geographically, the business activities are carried out through China and it exports the product mainly to the European and American countries.

Executives

Huang Xi Wei	Director
Liu Zu Qing	Supervisors
Xie Ju Hua	Director
Wu Gui Ping	senior management
Tang Yong Qun	Director
Qian Xiao Jie	senior management

Nanjing King-Friend Biochemical Pharmaceutical Co Headlines

No Headlines